nach oben

Erschienen in:

2013 | OriginalPaper | Buchkapitel

12. Hepatitisviren

verfasst von : Ioannis Mylonas, Stefan Wirth, Prof. Dr. med.

Erschienen in: Infektionserkrankungen der Schwangeren und des Neugeborenen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Das Spektrum der Lebererkrankungen nach einer Infektion mit hepatotropen Viren reicht von einem klinisch vollkommen blanden über einen cholestatischen Verlauf bis zum akuten Leberversagen. Die Erkrankungen sind selten und können teilweise durch eine zeitgerechte und adäquate Prävention oder postpartale Überwachung vermieden oder zumindest angemessen eingeschätzt werden. Die klassischen Hepatitisviren umfassen die Hepatitiden A bis E (Tab. 12.1). Darüber hinaus wurden in neuerer Zeit das Hepatitis-G-Virus und das TT-Virus charakterisiert. In Tab. 12.2 sind die in Europa relevanten hepatotropen Viren mit möglichem Krankheitswert dargestellt.

Beniwal M, Kumar A, Kar P et al (2003) Prevalence and severity of acute viral hepatitis and fulminant hepatitis during pregnancy: a prospective study from north India. Indian J Med Microbiol 21:184–185PubMed

Duff P (1998) Hepatitis in pregnancy. Semin Perinatol 22:277–283PubMedCrossRef

Duff B, Duff P (1998) Hepatitis A vaccine: ready for prime time. Obstet Gynecol 91:468–471PubMedCrossRef

Elinav E, Ben-Dov IZ, Shapira Y et al (2006) Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 130:1129–1134PubMedCrossRef

Erkan T, Kutlu T, Cullu F et al (1998) A case of vertical transmission of hepatitis A virus infection. Acta Paediatr 87:1008–1009PubMedCrossRef

Fagan EA, Hadzic N, Saxena R et al (1999) Symptomatic neonatal hepatitis A disease from a virus variant acquired in utero. Pediatr Infect Dis J 18:389–391PubMedCrossRef

Friese K, Schäfer A, Hof H (2003) Infektionskrankheiten in Gynäkologie und Geburtshilfe. Springer, Berlin

Hallam A, Kerlin P (1991) Viral hepatitis A to E. An update. Aust Fam Physician 20:760 (762–763, 766–770)PubMed

Leikin E, Lysikiewicz A, Garry D et al (1996) Intrauterine transmission of hepatitis A virus. Obstet Gynecol 88:690–691PubMedCrossRef

Mcduffie Jr. RS, Bader T (1999) Fetal meconium peritonitis after maternal hepatitis A. Am J Obstet Gynecol 180:1031–1032PubMedCrossRef

Motte A, Blanc J, Minodier P et al (2009) Acute hepatitis A in a pregnant woman at delivery. Int J Infect Dis 13:e49–51PubMedCrossRef

Mylonas I, Friese K (2009) Infektionen in der Gynäkologie und Geburtshilfe. Elsevier Urban, München

Mylonas I, Friese K (2010) Infektionen in der Geburtshilfe. In: Schneider H, Husslein P, Schneider KTM (Hrsg) Die Geburtshilfe. Springer, Heidelberg, S 379–434

Mylonas I, Bauerfeind I, Friese K (2005) Impfungen in der Schwangerschaft. Der Gynäkologe 38:771–779CrossRef

Mylonas I, Gingelmaier A, Friese K (2006) Systemische Infektionen in der Geburtshilfe. Der Gynäkologe 39:223–232CrossRef

Renge RL, Dani VS, Chitambar SD et al (2002) Vertical transmission of hepatitis A. Indian J Pediatr 69:535–536PubMedCrossRef

Siegl G (2004) Hepatitis A and E enterically transmitted virus infections of the liver. Ther Umsch 61:481–448PubMedCrossRef

Thomas HC, Lemon S, Zuckerman AJ (2005) Viral Hepatitis, 3. Aufl. Blackwell Publishing, LtdCrossRef

Urganci N, Arapoglu M, Akyildiz B, Nuhoglu A (2003) Neonatal cholestasis resulting from vertical transmission of hepatitis A infection. Pediatr Infect Dis J 22:381–382PubMed

Victor JC, Monto AS, Surdina TY (2007) Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 357:1685–1694PubMedCrossRef

Watson JC, Fleming DW, Borella AJ et al (1993) Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. J Infect Dis 167:567–571PubMedCrossRef

Zhu SS, Zhang HF, Yang XJ, Tang HM, Wu SX (2003) Clinical features of hepatitis A in 1,629 children. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 17:91–93PubMed

American College of Obstetricians and Gynecologists (ACOG) (2007) Viral Hepatitis in Pregnancy. ACOG Practice Bulletin, number 86

Bortolotti F, Guido M, Bartolacci S, Cadrobbi P, Morsica G, Noventa F, Crivellaro C et al (2006) Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 43:556–562PubMedCrossRef

Bundesamt für Gesundheit (2011) Übertragbare Krankheiten. Bulletin 10/11:196–204

Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF (2004) Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 116:829–834PubMedCrossRef

Cornberg M, Manns MP (2011) Prävention der Virushepatitis A bis E. Internist 52:250–264PubMedCrossRef

Cornberg M, Protzer U, Dollinger MM et al (2007) Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus(HBV-)Infektion. „Upgrade“ der Leitlinie, AWMF-Register-Nr. 021/011. Z Gastroenterol 45:1–50

Ferenci P (2009) Hepatitis B und Schwangerschaft. J Gastroenterol Hepatol Erkr 7:26–29

Friese K, Schäfer A, Hof H (2003) Infektionskrankheiten in Gynäkologie und Geburtshilfe. Springer, Berlin

Hsu HY, Chang MH, Lee CY, Chen JS, Hsu HC, Chen DS (1992) Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 15:382–386PubMedCrossRef

Jonas MM, Mizerski J, Badia IB, Areias JA, Greensmith MJ, Little NR, Schwarz KB et al (2002) Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 346:1706–1713PubMedCrossRef

Krause G (2007) Meldepflicht für Infektionskrankheiten. Dtsch Arztebl 104:A2811–2820

Laubscher B, Gehri M, Roulet M, Wirth S, Gerner P (2005) Survival of infantile fulminant hepatitis B and treatment with Lamivudine. J Pediatr Gastroenterol Nutr 40:518–520PubMedCrossRef

Lee PI, Lee CY, Huang LM, Chang MH (1995) Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr 126:716–721PubMedCrossRef

López M, Coll O (2010) Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations. Fetal Diagn Ther 28:1–8PubMedCrossRef

Mylonas I, Friese K (2009) Infektionen in der Gynäkologie und Geburtshilfe. Elsevier, Urban, München

Robert-Koch-Institut (2010) Zur Situation bei wichtigen Infektionskrankheiten in Deutschland. Virushepatitis B, C und D im Jahr 2009. Epid Bull 20:177–190

Schrag SJ, Arnold KE, Mohle-Boetani JC et al (2003) Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 102:753–760PubMedCrossRef

Sokal EM, Kelly DA, Mizerski J, Badia IB, Vegnente A, Schwarz KB, Areias JA et al (2006) Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 43:225–232PubMedCrossRef

Thierfelder W, Hellenbrand W, Meisel H et al (2001) Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 17:429–435PubMedCrossRef

Tran TT (2009) Management of hepatitis B in pregnancy: weighing the options. Clev Clin J Med 76(Suppl 3):S25–S29CrossRef

Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436–2441PubMed

Bhola K, McGuire W (2007) Does avoidance of breast feeding reduce mother-to-infant transmission of hepatitis C virus infection? Arch Dis Child 92:365–366PubMedCrossRef

Bortolotti F, Verucchi G, Camma C, Cabibbo G, Giacchino R, Indolfi G, Zancan L et al (2008) Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease. Gastroenterology 134(7):1900–1907PubMedCrossRef

Bourlet T, Levy R, Maertens A, Tardy JC, Grattard F, Cordonier H, Laurent JL, Guerin JF, Pozzetto B (2002) Detection and characterization of hepatitis C virus RNA in seminal plasma and spermatozoon fractions of semen from patients attempting medically assisted conception. J Clin Microbiol 40:3252–3255PubMedCrossRef

Boxall E, Baumann K, Price N, Sira J, Brown M, Kelly D (2007) Discordant outcome of perinatal transmission of hepatitis C in twin pregnancies. J Clin Virol 38:91–95PubMedCrossRef

Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G (1999) Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22–26PubMedCrossRef

Ceci O, Margiotta M, Marello F, Francavilla R, Loizzi P, Francavilla A, Mautone A, Impedovo L, Ierardi E, Mastroianni M, Bettocchi S, Selvaggi L (2001) Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr 33:570–575PubMedCrossRef

Conte D, Fraquelli M, Prati D, Colucci A, Minola E (2000) Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31:751–755PubMedCrossRef

Dal Molin G, D’Agaro P, Ansaldi F, Ciana G, Fertz C, Alberico S, Campello C (2002) Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J Med Virol 67:137–142CrossRef

England K, Pembrey L, Tovo PA, Newell ML (2005) Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr 94:444–450PubMedCrossRef

European Paediatric Hepatitis C Virus Network (2001) Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG 108:371–377CrossRef

Friese K, Schäfer A, Hof H (2003) Infektionskrankheiten in Gynäkologie und Geburtshilfe. Springer, Berlin

Friese K, Mörike K, Neumann G, Windorfer A (2009) Arzneimittel in der Schwangerschaft und Stillzeit: Ein Leitfaden für Ärzte und Apotheker. Wissenschaftliche Verlagsgesellschaft, Stuttgart

Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, Butler K (2000) Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 356:904–907PubMedCrossRef

Hayashida A, Inaba N, Oshima K, Nishikawa M, Negishi M, Hayashida S, Shoda A et al (2007) Re-evaluation of the true rate of hepatitis C virus mother-to-child transmission and its novel risk factors based on our two prospective studies. J Obstet Gynaecol Res 33:417–422PubMedCrossRef

Jara P, Hierro L, de la Vega A, Diaz C, Minos-Bartolo G, Frauca E, Camarena C et al (2008) Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. Pediatr Infect Dis J 27:142–148PubMed

Maheshwari A, Ray S, Thuluvath PJ (2008) Acute hepatitis C. Lancet 372:321–332PubMedCrossRef

Marine-Barjoan E, Berrebi A, Giordanengo V, Favre SF, Haas H, Moreigne M, Izopet J, Tricoire J, Tran A, Pradier C, Bongain A (2007) HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus? AIDS 21:1811–1815PubMedCrossRef

Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, Alter MJ (2005) Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 192:1880–1889PubMedCrossRef

Mylonas I, Friese K (2009) Infektionen in der Gynäkologie und Geburtshilfe. Elsevier, Urban, München

Nakashima K, Ikematsu H, Hayashi J, Kishihara Y, Mutsutake A, Kashiwagi S (1995) Intrafamilial transmission of hepatitis-C virus among the population of an endemic area of Japan. JAMA 274:1459–1461PubMedCrossRef

Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata C, Matsui A, Ujiie N, Endo C, Kako M et al (1994) Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 330:744–750PubMedCrossRef

Polywka S, Schroter M, Feucht HH, Zollner B, Laufs R (1999) Low risk of vertical transmission of hepatitis C virus by breast milk. Clin Infect Dis 29:1327–1329PubMedCrossRef

Polywka S, Feucht H, Laufs R (2003) Die chronische Hepatitis C der Mutter ist keine Kontraindikation für das Stillen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 46:739–743CrossRef

Polywka S, Pembrey L, Tovo PA, Newell ML (2006) Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol 78:305–310PubMedCrossRef

Resti M, Azzari C, Galli L, Zuin G, Giacchino R, Bortolotti F, Marcellini M, Moriondo M, de Martino M, Vierucci A (2002) Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 185:567–572PubMedCrossRef

Sarrazin C, Berg T, Ross RS et al (2010) Update der S3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus (HCV-)Infektion. „Upgrade“ der Leitlinie, AWMF-Register-Nr. 021/012. Z Gastroenterol 48:289–351PubMedCrossRef

Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H (2003) Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 187:345–351PubMedCrossRef

Tovo PA, Palomba E, Ferraris G, Principi N, Ruga E, Dallacasa P, Maccabruni A (1997) Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis 25:1121–1124PubMedCrossRef

Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP (2006) Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology 43:250–256PubMedCrossRef

Wirth S, Pieper-Boustani H, Lang T, Ballauff A, Wintermeyer P, Gerner P, Kullmer U et al (2005) Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 41:1013–1018PubMedCrossRef

Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, D’Amico E, Cambie G, Vecchi L (1995) Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 345:289–291PubMedCrossRef

Zanetti AR, Tanzi E, Romano L, Principi N, Zuin G, Minola E, Hunt J, Palmieri M, Marini A, Ghisotti D, Friedman P, Zapparoli B et al (1998) Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal Hepatitis Viruses Transmission. J Med Virol 54:107–112PubMedCrossRef

Bart PA, Jacquier P, Zuber PL et al (1996) Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery. Liver 16:110–116PubMed

Castelnau C, Le Gal F, Ripault MP et al (2006) Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 44:728–735PubMedCrossRef

Erhardt A, Gerlich W, Starke C et al (2006) Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int 26:805–810PubMedCrossRef

Flores R, Grubb D, Elleuch A et al (2011) Rolling-circle replication of viroids, viroid-like satellite RNAs and hepatitis delta virus: Variations on a theme. RNA Biol 8(2):200–206PubMedCrossRef

Huang YH, Wu JC, Lu SN, Chiang TY, Chang FY, Lee SD (1999) Phylogenetic analysis to document a common source of hepatitis D virus infection in a mother and her child. Zhonghua Yi Xue Za Zhi (Taipei) 62:28–32

Lau JY, Smith HM, Chaggar K et al (1991) Significance of IgM anti-hepatitis D virus (HDV) in chronic HDV infection. J Med Virol 33:273–276PubMedCrossRef

Le Gal F, Gordien E, Affolabi D et al (2005) Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 43:2363–2369PubMedCrossRef

Mansour W, Ducancelle A, Le Gal F et al (2010) Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. J Clin Virol 47:97–99PubMedCrossRef

Pascarella S, Negro F (2011) Hepatitis D virus: an update. Liver Int 31:7–21PubMedCrossRef

Ramia S, Bahakim H (1988) Perinatal transmission of hepatitis B virus-associated hepatitis D virus. Ann Inst Pasteur Virol 139:285–290PubMedCrossRef

Rizzetto M (2010) Hepatitis D: clinical features and therapy. Dig Dis 28:139–143PubMedCrossRef

Shattock AG, Morris MC (1991) Evaluation of commercial enzyme immunoassays for detection of hepatitis delta antigen and anti-hepatitis delta virus (HDV) and immunoglobulin M anti-HDV antibodies. J Clin Microbiol 29:1873–1876PubMed

Sureau C (2010) The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model. Methods Mol Biol 640:463–473PubMedCrossRef

Tang JR, Cova L, Lamelin JP et al (1994) Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA hybridization and polymerase chain reaction. J Hepatol 21:953–960PubMedCrossRef

Aboulata AA, Ahmad MS, Shaban MM, Zayd KM, Abd El-Moktader AM (2005) Prevalence of hepatitis E virus in Egyptian children presented with minor hepatic disorders. Egypt J Immunol 12:71–76PubMed

Bi SL, Purdy MA, Mccaustland KA et al (1993) The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China. Virus Res 28:233–247PubMedCrossRef

Bose PD, Das BC, Kumar A et al (2010) High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcome. J Hepatol 54(6):1107–1113PubMedCrossRef

Buti M, Plans P, Dominguez A, Jardi R, Salleras L, Esteban R, Rodriguez Frias F et al (2008) Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol 15:732–734PubMedCrossRef

Chibber RM, Usmani MA, Al-Sibai MH (2004) Should HEV infected mothers breast feed? Arch Gynecol Obstet 270:15–20PubMedCrossRef

Dalton HR, Fellows HJ, Stableforth W et al (2007) The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 26:1429–1435PubMedCrossRef

Dalton HR, Bendall RP, Keane FE et al (2009) Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 361:1025–1027PubMedCrossRef

Favorov MO, Fields HA, Purdy MA et al (1992) Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 36:246–250PubMedCrossRef

Gerolami R, Moal V, Picard C et al (2009) Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 50:622–624PubMedCrossRef

Green KY, Ando T, Balayan MS et al (2000) Taxonomy of the caliciviruses. J Infect Dis 181(Suppl 2):322–330CrossRef

Haagsma EB, Niesters HG, Van Den Berg AP et al (2009) Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 15:1225–1228PubMedCrossRef

Khuroo MS, Teli MR, Skidmore S et al (1981) Incidence and severity of viral hepatitis in pregnancy. Am J Med 70:252–255PubMedCrossRef

Khuroo MS, Kamili S, Jameel S (1995) Vertical transmission of hepatitis E virus. Lancet 345:1025–1026PubMedCrossRef

Khuroo MS, Kamili S, Yattoo GN (2004) Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 19:778–784PubMedCrossRef

Kumar A, Beniwal M, Kar P et al (2004) Hepatitis E in pregnancy. Int J Gynaecol Obstet 85:240–244PubMedCrossRef

Matsubayashi K, Nagaoka Y, Sakata H et al (2004) Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 44:934–940PubMedCrossRef

Naidu SS, Viswanathan R (1957) Infectious hepatitis in pregnancy during Delhi epidemic. Indian J Med Res 45:71–76PubMed

Naik SR, Aggarwal R, Salunke PN et al (1992) A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 70:597–604PubMed

Ollier L, Tieulie N, Sanderson F et al (2009) Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 150:430–431PubMedCrossRef

Ramalingaswami V, Purcell RH (1988) Waterborne non-A, non-B hepatitis. Lancet 1:571–573PubMedCrossRef

Shukla P, Chauhan UK, Naik S et al (2007) Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J Viral Hepat 14:310–317PubMedCrossRef

Stoszek SK, Abdel-Hamid M, Saleh DA et al (2006) High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 100:95–101PubMedCrossRef

Teshale EH, Grytdal SP, Howard C et al (2010) Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 50:1006–1010PubMedCrossRef

Teshale EH, Hu DJ, Holmberg SD (2010) The two faces of hepatitis E virus. Clin Infect Dis 51:328–334PubMedCrossRef

Tsega E, Krawczynski K, Hansson BG et al (1993) Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 31:173–181PubMed

Viswanathan R (1957) Infectious hepatitis in Delhi (1955–1956). A critical study: epidemiology. Indian J Med Res 45:49–58PubMed

Zhu FC, Zhang J, Zhang XF et al (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376:895–902PubMedCrossRef

Zhuang H, Cao XY, Liu CB et al (1991) Epidemiology of hepatitis E in China. Gastroenterol Jpn 26(Suppl 3):135–138PubMed

American College of Obstetricians and Gynecologists (2007) ACOG Practice Bulletin No. 86: Viral hepatitis in pregnancy. Obstet Gynecol 110(4):941–956CrossRef

Bundesamt für Gesundheit (2011) Übertragbare Krankheiten. Bulletin 10/11:196–204

Cornberg M, Manns MP (2011) Prävention der Virushepatitis A bis E. Internist 52:250–264PubMedCrossRef

Krause G (2007) Meldepflicht für Infektionskrankheiten. Dt Ärztebl 104:A2811–2820

López M, Coll O (2010) Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations. Fetal Diagn Ther 28:1–8PubMedCrossRef

Robert-Koch-Institut (2008) Zur Situation der Hepatitis A in Deutschland im Jahr 2007. Epid Bull 44:379–384

Robert-Koch-Institut (2008) Hepatitis E – Epidemiologie und Risikofaktoren in Deutschland. Epid Bull 49:435–446

Robert-Koch-Institut (2010) Zur Situation bei wichtigen Infektionskrankheiten in Deutschland. Virushepatitis B, C und D im Jahr 2009. Epid Bull 20:177–190

Schrag SJ, Arnold KE, Mohle-Boetani JC et al (2003) Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 102:753–760PubMedCrossRef

Titel: Hepatitisviren
verfasst von: Ioannis Mylonas
Stefan Wirth, Prof. Dr. med.
Verlag: Springer Berlin Heidelberg
Buch: Infektionserkrankungen der Schwangeren und des Neugeborenen
Print ISBN: 978-3-540-78324-4

Electronic ISBN: 978-3-540-78325-1

Copyright-Jahr: 2013
DOI: https://doi.org/10.1007/978-3-540-78325-1_12

Neu im Fachgebiet Gynäkologie und Geburtshilfe

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

12. Hepatitisviren

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Gynäkologie